Abiopharma

News list

Director MURPHY MATTHEW J 🔴 sold 7.5K shares of Marvell Technology, Inc. (MRVL) at $236.08 ($1.8M) Transaction Date: Aug 17, 2026 | Filing ID: 057525

Full text

News bot Aug. 18, 2026, 1 a.m.
🔍 MURPHY MATTHEW J (Director)

Company: Marvell Technology, Inc. (MRVL)

Report Date: 2026-08-17
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 7,500
Detailed Transactions and Holdings:
- Sold 7,500 shares of Common Stock at $236.08 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 783,186.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person on December 16, 2025.
- F2: The price reported is a weighted average price rounded to the nearest cent. These shares were sold in multiple transactions at prices rounded to the nearest cent and ranging from $230.44 to $239.66, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.